5-(tert-Butyl)-2-hydroxy-3-methylbenzaldehyde

Catalog No.: 
ACRXGM032
CAS No.: 
1666-01-9
Molecular Formula: 
C12H16O2
Molecular Weight: 
192.26
5-(tert-Butyl)-2-hydroxy-3-methylbenzaldehyde structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$141.00In stockIn stock
100mg95%$226.00In stockIn stock
250mg95%$387.00In stockIn stock
1g95%$775.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-(tert-Butyl)-2-hydroxy-3-methylbenzaldehyde
IUPAC Name5-(tert-butyl)-2-hydroxy-3-methylbenzaldehyde
MDL No.MFCD16743013
Molecular FormulaC12H16O2
Molecular Weight192.26
SMILESO=CC1=CC(C(C)(C)C)=CC(C)=C1O
InChI KeyVCYNSDGWNABYBX-UHFFFAOYSA-N
Synonym5-tert-Butyl-2-hydroxy-3-methyl-benzaldehyde;Benzaldehyde, 5-(1,1-dimethylethyl)-2-hydroxy-3-methyl-
CAS No.1666-01-9

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Danger
Hazard Statement(s)
H302-H315-H318-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P310-P330-P332+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACRXGM032 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACNTVF895 route compound structure diagram
    ACNTVF89598-27-1In Stock
  4. Then
  5. ACRXGM032 route product structure diagram
    ACRXGM0321666-01-9In Stock
Inquiry

2. ACRXGM032 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRXGM032 route product structure diagram
    ACRXGM0321666-01-9In Stock
Inquiry

3. ACRXGM032 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRXGM032 route product structure diagram
    ACRXGM0321666-01-9In Stock
Inquiry

Comments (0)